Medicare's Temporary Bonus Payments Are Nudging Hospitals to Try AI Devices
A little-known Medicare incentive gives hospitals extra money to use new AI medical devices for a few years — before anyone knows if the tech actually saves money long-term.
What happened: STAT News published the fourth part of its ongoing investigation, "Paying for AI," looking at how Medicare's payment system shapes which artificial intelligence tools actually make it into hospitals. The focus this time: a temporary add-on payment that Medicare offers for certain new medical technologies, including some AI-based devices, for two to three years after they launch.
Why it matters: Hospitals don't just adopt a new AI tool because it might catch a dangerous condition early. According to the reporting, technology is far more likely to stick around long-term if it can also show it lowers costs. That makes the financial case just as important as the clinical one when a hospital decides whether to buy in — and Medicare's incentive payments are one of the levers nudging that decision.
How it works, plainly: Medicare's add-on payment program is designed to help new, often expensive, medical technologies reach patients sooner by temporarily covering more of the cost. A device or tool that qualifies gets extra reimbursement for two to three years, funded by tax dollars, on top of what Medicare normally pays for the underlying treatment. The idea is to soften the financial risk for hospitals while a technology is still new and unproven at scale.
The rollout: This is one entry in a longer STAT series examining how new clinical AI tools affect both the affordability of health care and patients' long-term health outcomes. The underlying tension carries forward: these Medicare payments are temporary by design, which raises the question of what happens to an AI tool's adoption once the extra funding runs out and hospitals must judge it on its own financial and clinical merits.